Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1199989019 | Theophylline, anhydrous 400mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1213070019 | Theophylline, anhydrous 400mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3471891019 | Product containing theophylline, anhydrous 400 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3489919013 | Product containing theophylline, anhydrous 400 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501250013 | Theophylline, anhydrous 400 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568135013 | Product containing only theophylline, anhydrous 400 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568136014 | Product containing only theophylline, anhydrous 400 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683485019 | Theophylline anhydrous 400 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3683486018 | Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683487010 | Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 108297001000001110 | Theophylline, anhydrous 400 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Is a | Product containing theophylline | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Is a | Theophylline m/r | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has active ingredient | Theophylline | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has active ingredient | Smooth muscle relaxant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has active ingredient | Theophylline anhydrous | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has active ingredient | Xanthine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has active ingredient | Musculoskeletal system agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Is a | Product containing theophylline in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has active ingredient | Theophylline anhydrous | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has basis of strength substance | Theophylline anhydrous | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 400 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has precise active ingredient | Theophylline anhydrous | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral tablet | Is a | Product containing only theophylline in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR